ID

41386

Beschrijving

Non-interventional Local Study on Prescription Behavior of Anticoagulation Therapy in Secondary Stroke Prevention in Atrial Fibrillation Patients; ODM derived from: https://clinicaltrials.gov/show/NCT01925755

Link

https://clinicaltrials.gov/show/NCT01925755

Trefwoorden

  1. 19-01-19 19-01-19 -
  2. 28-09-20 28-09-20 -
Houder van rechten

see on clinicaltrials.gov

Geüploaded op

28 september 2020

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0

Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Stroke Secondary to Atrial Fibrillation, NCT01925755

Eligibility Stroke Secondary to Atrial Fibrillation, NCT01925755

Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
male and female patients ≥ 18 years old who start treatment with rivaroxaban
Beschrijving

Age, Gender, Start of Rivaroxaban

Datatype

boolean

Alias
UMLS CUI [1]
C0079399
UMLS CUI [2]
C0001779
UMLS CUI [3,1]
C1739768
UMLS CUI [3,2]
C0439659
non-valvular atrial fibrillation is documented in patients' file
Beschrijving

Non-valvular Atrial fibrillation

Datatype

boolean

Alias
UMLS CUI [1,1]
C0004238
UMLS CUI [1,2]
C0018826
UMLS CUI [1,3]
C1314939
UMLS CUI [1,4]
C0332197
prior tia/stroke history
Beschrijving

Tia/stroke history

Datatype

boolean

Alias
UMLS CUI [1]
C0559159
UMLS CUI [2]
C0455536
if tia - more than 72 hours after documented tia
Beschrijving

Tia more than 72 hours ago

Datatype

boolean

Alias
UMLS CUI [1,1]
C0231290
UMLS CUI [1,2]
C0007787
if stroke - more than 2 weeks after non-hemorrhagic stroke
Beschrijving

Non-hemorrhagic stroke more than 2 weeks ago

Datatype

boolean

Alias
UMLS CUI [1,1]
C0038454
UMLS CUI [1,2]
C0231290
written informed consent
Beschrijving

Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
contraindications for use of xarelto® in accordance with approved product label
Beschrijving

Contraindications Xarelto®

Datatype

boolean

Alias
UMLS CUI [1,1]
C1739768
UMLS CUI [1,2]
C0522473
previous thromboprophylaxis treatment for stroke/tia prevention
Beschrijving

Anticoagulant prophylaxis for stroke/tia prevention

Datatype

boolean

Alias
UMLS CUI [1]
C0199242
UMLS CUI [2,1]
C0948008
UMLS CUI [2,2]
C0199176
UMLS CUI [3,1]
C0007787
UMLS CUI [3,2]
C0199176
any reasons of medical and non-medical character, which in the opinion of the physician can hamper patient participation in nis
Beschrijving

Other reason affecting participation

Datatype

boolean

Alias
UMLS CUI [1,1]
C3840932
UMLS CUI [1,2]
C0392760
UMLS CUI [1,3]
C2348568
UMLS CUI [1,4]
C0022423
UMLS CUI [1,5]
C0031831

Similar models

Eligibility Stroke Secondary to Atrial Fibrillation, NCT01925755

Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Age, Gender, Start of Rivaroxaban
Item
male and female patients ≥ 18 years old who start treatment with rivaroxaban
boolean
C0079399 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
C1739768 (UMLS CUI [3,1])
C0439659 (UMLS CUI [3,2])
Non-valvular Atrial fibrillation
Item
non-valvular atrial fibrillation is documented in patients' file
boolean
C0004238 (UMLS CUI [1,1])
C0018826 (UMLS CUI [1,2])
C1314939 (UMLS CUI [1,3])
C0332197 (UMLS CUI [1,4])
Tia/stroke history
Item
prior tia/stroke history
boolean
C0559159 (UMLS CUI [1])
C0455536 (UMLS CUI [2])
Tia more than 72 hours ago
Item
if tia - more than 72 hours after documented tia
boolean
C0231290 (UMLS CUI [1,1])
C0007787 (UMLS CUI [1,2])
Non-hemorrhagic stroke more than 2 weeks ago
Item
if stroke - more than 2 weeks after non-hemorrhagic stroke
boolean
C0038454 (UMLS CUI [1,1])
C0231290 (UMLS CUI [1,2])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Contraindications Xarelto®
Item
contraindications for use of xarelto® in accordance with approved product label
boolean
C1739768 (UMLS CUI [1,1])
C0522473 (UMLS CUI [1,2])
Anticoagulant prophylaxis for stroke/tia prevention
Item
previous thromboprophylaxis treatment for stroke/tia prevention
boolean
C0199242 (UMLS CUI [1])
C0948008 (UMLS CUI [2,1])
C0199176 (UMLS CUI [2,2])
C0007787 (UMLS CUI [3,1])
C0199176 (UMLS CUI [3,2])
Other reason affecting participation
Item
any reasons of medical and non-medical character, which in the opinion of the physician can hamper patient participation in nis
boolean
C3840932 (UMLS CUI [1,1])
C0392760 (UMLS CUI [1,2])
C2348568 (UMLS CUI [1,3])
C0022423 (UMLS CUI [1,4])
C0031831 (UMLS CUI [1,5])

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial